LOTTE CHEMICAL TITAN HOLDING |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.09 MYR | 0.00% |
|
+0.93% | -19.26% |
| Mar. 07 | Lotte Chemical Titan Holding Berhad Announces Resignation of Ong E-Shynn as Joint Secretary | CI |
| Jan. 30 | Lotte Chemical Titan Narrows Loss in Q4 | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,478 | 6,296 | 5,466 | 3,234 | 3,075 | 2,483 | - | - |
| Enterprise Value (EV) 1 | 1,562 | 2,138 | 868 | 1,914 | 8,245 | 10,809 | 13,362 | 13,915 |
| P/E ratio | 12.5 x | 42.4 x | 5.16 x | -4.53 x | -3.94 x | -3.23 x | 9.69 x | 11.7 x |
| Yield | 2.9% | 1.18% | 16.3% | - | - | - | 0.92% | 2.14% |
| Capitalization / Revenue | 0.65 x | 0.91 x | 0.56 x | 0.32 x | 0.4 x | 0.31 x | 0.29 x | 0.24 x |
| EV / Revenue | 0.19 x | 0.31 x | 0.09 x | 0.19 x | 1.08 x | 1.36 x | 1.58 x | 1.37 x |
| EV / EBITDA | 1.75 x | 2.58 x | 0.53 x | -4.19 x | -23.1 x | -42.1 x | 15.9 x | 12.9 x |
| EV / FCF | 2.88 x | 8.51 x | 1.21 x | -0.41 x | -1.16 x | -2.26 x | -6.76 x | -21.9 x |
| FCF Yield | 34.8% | 11.7% | 82.8% | -245% | -86.5% | -44.3% | -14.8% | -4.57% |
| Price to Book | 0.46 x | 0.53 x | 0.43 x | 0.27 x | 0.27 x | 0.23 x | 0.23 x | 0.24 x |
| Nbr of stocks (in thousands) | 2,272,984 | 2,272,984 | 2,277,557 | 2,277,557 | 2,277,557 | 2,277,557 | - | - |
| Reference price 2 | 2.410 | 2.770 | 2.400 | 1.420 | 1.350 | 1.090 | 1.090 | 1.090 |
| Announcement Date | 1/30/20 | 1/27/21 | 1/27/22 | 1/31/23 | 1/29/24 | - | - | - |
1MYR in Million2MYR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8,438 | 6,901 | 9,831 | 10,019 | 7,646 | 7,926 | 8,474 | 10,138 |
| EBITDA 1 | 891.2 | 830.3 | 1,647 | -457.1 | -357.1 | -256.6 | 839.4 | 1,076 |
| EBIT 1 | 259.9 | 272 | 1,091 | -1,041 | -868 | -794.5 | 48.7 | -113.4 |
| Operating Margin | 3.08% | 3.94% | 11.1% | -10.39% | -11.35% | -10.02% | 0.57% | -1.12% |
| Earnings before Tax (EBT) 1 | 503.3 | 204 | 1,351 | -985.1 | -999.6 | -1,041 | 340.6 | -80.95 |
| Net income 1 | 442.6 | 154 | 1,058 | -714.6 | -780.3 | -766 | 256.6 | 212.2 |
| Net margin | 5.24% | 2.23% | 10.76% | -7.13% | -10.2% | -9.66% | 3.03% | 2.09% |
| EPS 2 | 0.1935 | 0.0654 | 0.4649 | -0.3138 | -0.3426 | -0.3370 | 0.1125 | 0.0930 |
| Free Cash Flow 1 | 543 | 251.2 | 718.3 | -4,687 | -7,133 | -4,786 | -1,976 | -635.3 |
| FCF margin | 6.43% | 3.64% | 7.31% | -46.78% | -93.29% | -60.38% | -23.32% | -6.27% |
| FCF Conversion (EBITDA) | 60.93% | 30.25% | 43.6% | - | - | - | - | - |
| FCF Conversion (Net income) | 122.69% | 163.07% | 67.9% | - | - | - | - | - |
| Dividend per Share 2 | 0.0700 | 0.0327 | 0.3900 | - | - | - | 0.0100 | 0.0233 |
| Announcement Date | 1/30/20 | 1/27/21 | 1/27/22 | 1/31/23 | 1/29/24 | - | - | - |
1MYR in Million2MYR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q3 |
|---|---|---|
| Net sales 1 | - | 1,961 |
| EBITDA 1 | - | 98.76 |
| EBIT | - | - |
| Operating Margin | - | - |
| Earnings before Tax (EBT) | - | - |
| Net income | -224.8 | - |
| Net margin | - | - |
| EPS | -0.0987 | - |
| Dividend per Share | - | - |
| Announcement Date | 4/27/23 | 10/26/23 |
1MYR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 5,170 | 8,327 | 10,880 | 11,432 |
| Net Cash position 1 | 3,916 | 4,158 | 4,598 | 1,320 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -14.48 x | -32.46 x | 12.96 x | 10.63 x |
| Free Cash Flow 1 | 543 | 251 | 718 | -4,687 | -7,133 | -4,786 | -1,976 | -635 |
| ROE (net income / shareholders' equity) | 3.67% | 1.25% | 8.63% | -5.84% | -6.71% | -4.8% | -1.94% | -4.55% |
| ROA (Net income/ Total Assets) | 3.21% | 1.07% | 7.2% | -4.43% | -3.91% | -2.02% | -0.41% | -1.64% |
| Assets 1 | 13,778 | 14,390 | 14,700 | 16,131 | 19,947 | 37,983 | -63,110 | -12,936 |
| Book Value Per Share 2 | 5.260 | 5.190 | 5.590 | 5.170 | 5.050 | 4.810 | 4.690 | 4.560 |
| Cash Flow per Share | 0.4800 | 0.4700 | 0.5100 | - | - | - | - | - |
| Capex 1 | 543 | 826 | 449 | 4,409 | 6,509 | 4,473 | 1,968 | 275 |
| Capex / Sales | 6.44% | 11.96% | 4.57% | 44.01% | 85.13% | 56.43% | 23.23% | 2.71% |
| Announcement Date | 1/30/20 | 1/27/21 | 1/27/22 | 1/31/23 | 1/29/24 | - | - | - |
1MYR in Million2MYR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
1.09
MYR
Average target price
1.08
MYR
Spread / Average Target
-0.92%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.26% | 521M | |
| -25.15% | 20.6B | |
| -14.52% | 13.21B | |
| -8.75% | 9.69B | |
| -13.48% | 9.66B | |
| +4.49% | 6.61B | |
| +3.01% | 6.42B | |
| -30.31% | 5.29B | |
| -21.00% | 3.3B | |
| -34.73% | 3.06B |
- Stock Market
- Equities
- LCTITAN Stock
- Financials Lotte Chemical Titan Holding
